Genzyme and Osiris Sign Deal for First-in-Class Adult Stem Cell Products
By Taskin Ahmed
Pharma Deals Review: Vol 2008 Issue 102 (Table of Contents)
Published: 4 Nov-2008
DOI: 10.3833/pdr.v2008.i102.110 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Osiris Therapeutics and Genzyme struck a marketing deal for two adult stem cell treatments, Prochymal and Chondrogen, both of which are in clinical trials...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS